<DOC>
	<DOCNO>NCT02742701</DOCNO>
	<brief_summary>Diabetes prevalence palliative care 10-15 % . Most hospice patient treated insulin . The target glucose level high order decrease risk hypoglycemia . Glucose level usually monitor use capillary blood glucose three time daily . The aim research simplify pattern care end-of-life patient . It evaluate whether non invasive measurement glucose urine could replace measurement capillary blood glucose . The first objective ass performance measurement glucosuria use urinary dip stix predict blood glucose level within target range . Due high glucose target , hyperglycemia extremely frequent . However , symptom hyperglycemia unfrequently report . They may unspecific and/or mask end-of-life patient due terminal disease medication . The second objective study define symptom hyperglycemia patient .</brief_summary>
	<brief_title>Diabetes Palliative Care</brief_title>
	<detailed_description>This prospective study involve several palliative care unit France . Glycemia glycosuria measure patient . Symptoms could relate hyperglycemia assess relation concomitant blood glucose level . Main investigation : Glycosuria cetonuria measure use dip stix nursing care . Glycemia measure breakfast diner . Pain cause finger prick measurement glycemia evaluate use verbal scale . Symptoms evaluate time glucose measurement first open question list potential symptom hyperglycemia .</detailed_description>
	<criteria>diabetic patient hospitalise palliative care unit terminally ill cancer blood glucose measurement least twice daily 5 day agree participate study patient unable communicate , understand information study decline participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>